Skip to content

Exploring Acne Treatments Through Clinical Research Participation

Advancing Acne Care - Clinical Trials Open for Patient Enrollment

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07010458
Enrollment
500
Registered
2025-06-08
Start date
2026-06-30
Completion date
2028-06-30
Last updated
2025-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne

Keywords

Acne

Brief summary

The purpose of this study is to understand the lived experiences of acne patients enrolled in a related clinical trial testing a particular treatment. The primary focus will be on tracking trial adherence and dropout rates to enhance future research and care approaches, especially for underserved groups.

Interventions

None listed

Sponsors

Power Life Sciences Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with acne. * Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed * Subjects willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examination.

Exclusion criteria

* Refusal of consent * Women of childbearing potential without a negative pregnancy test; or women who are lactating. * Any serious and/or unstable pre-existing medical disorders

Design outcomes

Primary

MeasureTime frame
Rate of patients who decide to enroll in an acne clinical research.3 month
Number of acne study participants who remain in clinical study until completion.12 months

Countries

United States

Contacts

Primary ContactMichael B Gill
bask@withpower.com(415) 900-4227

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026